Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression

R. Mitchell Baldwin; Nasim Haghandish; Manijeh Daneshmand; Shahrier Amin; Geneviève Paris; Theresa J. Falls; John C. Bell; Shahidul Islam; Jocelyn Côté

doi:10.18632/oncotarget.3072

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression

R. Mitchell Baldwin, Nasim Haghandish, Manijeh Daneshmand, Shahrier Amin, Geneviève Paris, Theresa J. Falls, John C. Bell, Shahidul Islam and Jocelyn Côté _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:3013-3032. https://doi.org/10.18632/oncotarget.3072

Metrics: PDF 3495 views | HTML 4015 views | ?

Abstract

R. Mitchell Baldwin1,2, Nasim Haghandish1,2, Manijeh Daneshmand3,4, Shahrier Amin4,5, Geneviève Paris1,2, Theresa J. Falls3, John C. Bell3,6, Shahidul Islam4,5 and Jocelyn Côté1,2

1 Department of Cellular and Molecular Medicine, Ottawa, Ontario, Canada

2 Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada

3 Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

4 Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada

5 Department of Pathology, Ottawa Hospital, Ottawa, Ontario, Canada

6 Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada

Correspondence:

Jocelyn Côté, email:

Keywords: Protein arginine methyltransferase, PRMT7, breast cancer, invasion, MMP9

Received: September 30, 2014 Accepted: December 18, 2014 Published: December 26, 2014

Abstract

Recent evidence points to the protein arginine methyltransferase (PRMT) family of enzymes playing critical roles in cancer. PRMT7 has been identified in several gene expression studies to be associated with increased metastasis and decreased survival in breast cancer patients. However, this has not been extensively studied. Here we report that PRMT7 expression is significantly upregulated in both primary breast tumour tissues and in breast cancer lymph node metastases. We have demonstrated that reducing PRMT7 levels in invasive breast cancer cells using RNA interference significantly decreased cell invasion in vitro and metastasis in vivo. Conversely, overexpression of PRMT7 in non-aggressive MCF7 cells enhanced their invasiveness. Furthermore, we show that PRMT7 induces the expression of matrix metalloproteinase 9 (MMP9), a well-known mediator of breast cancer metastasis. Importantly, we significantly rescued invasion of aggressive breast cancer cells depleted of PRMT7 by the exogenous expression of MMP9. Our results demonstrate that upregulation of PRMT7 in breast cancer may have a significant role in promoting cell invasion through the regulation of MMP9. This identifies PRMT7 as a novel and potentially significant biomarker and therapeutic target for breast cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3072

Publication Alerts

Research Papers:

Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression

Abstract